tert-Butyl 7-bromo-4-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate

Catalog No. :
ACTJWA749
CAS No. :
3010260-09-7
Molecular Formula :
C14H18BrNO3
Molecular Weight :
328.21

IUPAC Name:tert-Butyl 7-bromo-4-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate

tert-Butyl 7-bromo-4-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$721.00Login to see priceIn stockInquiry
250mg95%$960.00Login to see priceIn stockInquiry
500mg95%$1607.00Login to see priceIn stockInquiry
1g95%$2398.00Login to see priceIn stockInquiry
5g95%$7194.00Login to see priceIn stockInquiry
10g95%$11989.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 7-bromo-4-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate
IUPAC Nametert-Butyl 7-bromo-4-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate
Molecular FormulaC14H18BrNO3
Molecular Weight328.21
SMILESO=C(N1CC2=C(C=CC(Br)=C2)C(O)C1)OC(C)(C)C
InChI KeyBYIBMAVFUKUFEU-UHFFFAOYSA-N
Synonymtert-butyl 7-bromo-4-hydroxy-3,4-dihydro-1H-isoquinoline-2-carboxylate;tert-Butyl 7-bromo-4-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate;2(1H)-Isoquinolinecarboxylic acid, 7-bromo-3,4-dihydro-4-hydroxy-, 1,1-dimethylethyl ester
CAS No.3010260-09-7

Synthetic Route by SureRoute

1. ACTJWA749 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPHLD380 route compound structure diagram
    ACPHLD3802385456-89-1 In Stock
  2. Then
  3. ACTJWA749 route product structure diagram
    ACTJWA7493010260-09-7 In Stock
Inquiry

2. ACTJWA749 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTJWA749 route product structure diagram
    ACTJWA7493010260-09-7 In Stock
Inquiry

Comments (0)